Molecular characterization of primary and secondary resistance to RET inhibitors in patients with advanced NSCLC and RET fusions

A. Marinello; D. Vasseur; N. Conci; C. Lindsay; G. Metro; R. Ferrara; A. Eisert; F. Citarella; V. Fallet; C. Audugier-Valette; S. Cousin; F. Tabbò; A. Russo; A. Calles Blanco; P. Iranzo Gomez; M. Tagliamento; L. Mezquita; S. Ponce; B. Besse; M. Aldea

doi:10.1016/S0959-8049(22)00871-1

Molecular characterization of primary and secondary resistance to RET inhibitors in patients with advanced NSCLC and RET fusions

A. Marinello, D. Vasseur, N. Conci, C. Lindsay, G. Metro, R. Ferrara, A. Eisert, F. Citarella, V. Fallet, C. Audugier-Valette, S. Cousin, F. Tabbò, A. Russo, A. Calles Blanco, P. Iranzo Gomez, M. Tagliamento, L. Mezquita, S. Ponce, B. Besse, M. Aldea

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S26
Journal	European Journal of Cancer
Volume	174
DOIs	https://doi.org/10.1016/S0959-8049(22)00871-1
Publication status	Published - Oct 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0959-8049(22)00871-1

Cite this

Marinello, A., Vasseur, D., Conci, N., Lindsay, C., Metro, G., Ferrara, R., Eisert, A., Citarella, F., Fallet, V., Audugier-Valette, C., Cousin, S., Tabbò, F., Russo, A., Calles Blanco, A., Iranzo Gomez, P., Tagliamento, M., Mezquita, L., Ponce, S., Besse, B., & Aldea, M. (2022). Molecular characterization of primary and secondary resistance to RET inhibitors in patients with advanced NSCLC and RET fusions. European Journal of Cancer, 174, S26. https://doi.org/10.1016/S0959-8049(22)00871-1

@article{2d37a89cf1b848398b514be7d2baf459,

title = "Molecular characterization of primary and secondary resistance to RET inhibitors in patients with advanced NSCLC and RET fusions",

author = "A. Marinello and D. Vasseur and N. Conci and C. Lindsay and G. Metro and R. Ferrara and A. Eisert and F. Citarella and V. Fallet and C. Audugier-Valette and S. Cousin and F. Tabb{\`o} and A. Russo and {Calles Blanco}, A. and {Iranzo Gomez}, P. and M. Tagliamento and L. Mezquita and S. Ponce and B. Besse and M. Aldea",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)00871-1",

language = "English",

volume = "174",

pages = "S26",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier BV",

}

Marinello, A, Vasseur, D, Conci, N, Lindsay, C, Metro, G, Ferrara, R, Eisert, A, Citarella, F, Fallet, V, Audugier-Valette, C, Cousin, S, Tabbò, F, Russo, A, Calles Blanco, A, Iranzo Gomez, P, Tagliamento, M, Mezquita, L, Ponce, S, Besse, B & Aldea, M 2022, 'Molecular characterization of primary and secondary resistance to RET inhibitors in patients with advanced NSCLC and RET fusions', European Journal of Cancer, vol. 174, pp. S26. https://doi.org/10.1016/S0959-8049(22)00871-1

TY - JOUR

T1 - Molecular characterization of primary and secondary resistance to RET inhibitors in patients with advanced NSCLC and RET fusions

AU - Marinello, A.

AU - Vasseur, D.

AU - Conci, N.

AU - Lindsay, C.

AU - Metro, G.

AU - Ferrara, R.

AU - Eisert, A.

AU - Citarella, F.

AU - Fallet, V.

AU - Audugier-Valette, C.

AU - Cousin, S.

AU - Tabbò, F.

AU - Russo, A.

AU - Calles Blanco, A.

AU - Iranzo Gomez, P.

AU - Tagliamento, M.

AU - Mezquita, L.

AU - Ponce, S.

AU - Besse, B.

AU - Aldea, M.

PY - 2022/10

Y1 - 2022/10

UR - http://www.scopus.com/inward/record.url?scp=85143769243&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(22)00871-1

DO - 10.1016/S0959-8049(22)00871-1

M3 - Article

AN - SCOPUS:85143769243

SN - 0959-8049

VL - 174

SP - S26

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Molecular characterization of primary and secondary resistance to RET inhibitors in patients with advanced NSCLC and RET fusions

UN SDGs

Access to Document

Other files and links

Cite this